Theranos founder Elizabeth Holmes takes stand in her criminal trial in surprise move by defense team

- Advertisement -


  • Theranos founder Elizabeth Holmes was called to the stand on Friday in her criminal trial.
  • After 11 weeks of witnesses were called by the prosecution, the defense began to present its case on Friday morning.
  • The defense did not indicate whether Holmes would testify.

- Advertisement -

SAN JOSE, Calif. — A smiling Elizabeth Holmes took the stand Friday to testify at her criminal trial, a sudden and surprising move by the defense team, which began its case earlier in the day.

- Advertisement -

Holmes, 37, faces 11 counts of wire fraud and conspiracy to commit wire fraud, and has pleaded not guilty. In the 11 weeks since her trial began, prosecutors called 29 witnesses, including former laboratory directors, patients, doctors, business partners and investors.

Following testimony on Thursday from Roger Parloff, a journalist who wrote 2014 Fortune magazine, the government put its case to rest on Friday morning. cover story, “This CEO is out for blood,” outlines Holmes.

- Advertisement -

Holmes’ defense attorneys did not indicate whether the founder and former CEO of the blood-testing company would take a stand. But she was called shortly after 3 p.m. California time and confidently went upstairs.

One of his defense attorneys, Kevin Downey, began the inquiry. In one of his first statements, Holmes said that between 2009 and 2010, his team made a technical breakthrough.

“We worked for years with teams of scientists and engineers to miniaturize all the techniques in the lab,” Holmes said.

Downey asked Holmes about her public announcements about how many tests Theranos could run and whether she was limiting her comments to certain types of tests. Holmes said, “No.”

Several company insiders, including whistleblower and former lab assistant Erica Cheung, testified that Theranos’ equipment could not run more than 12 different tests, contradicting the company’s announcements. Holmes told potential investors and others that Theranos’ proprietary technology could run 1,000 blood tests.

This is breaking news. Please check back for updates.

,

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox